Medios AG
Research Medios AG (0QB4) on Bullrun: P/E 26.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker0QB4
- ExchangeLSE
- CountryGermany
- CurrencyEUR
- P/E26.8
Valuation Snapshot
P/E is 26.8.
About Medios AG
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment also includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions.
Frequently asked questions
What is Medios AG's P/E ratio?
Medios AG's price-to-earnings (P/E) ratio is 26.8.
What does Medios AG do?
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply.